Andrew Gu
CIK: 0002137966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLRB
Cellectar Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Gu Andrew
Gu Andrew (SEC CIK 0002137966) files insider reports with the SEC as Director of Cellectar Biosciences, Inc. (CLRB).
Signal8 holds 2 ownership filings by Gu Andrew (1 Form 3, 1 Form 4), filed between Jun 9, 2026 and Jul 8, 2026. Those filings report 1 transaction, the latest on Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gu Andrew's filings is in FLORHAM PARK, NJ.
Recent filings by Gu Andrew
- Jul 7, 2026: Grant or award of CLRB derivative securities (Form 4, code A).
Other insiders filing for Cellectar Biosciences, Inc. (CLRB)
- Loren Stefan, Officer
- Kolean Chad J, CFO
- DRISCOLL FREDERICK W, Director
- Chanan-Khan Asher, Director
- CARUSO JAMES V, President & CEO
- Longcor Jarrod, Chief Operating Officer